x
0 Activities
0 Activities
No Saved Activities
Please wait
Home
Education
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
Search Education
Register
Contact Us
Login
Login
Remember Me
Log in
Create an account
Forgot your password?
Search
Format
Interactive Case
Podcast
Primers/Supplements
Webinar
Videos
View All Education
All France Foundation Content
Credit Type
Format
Credits
Specialty Area
Disease Area
Start
«
1
2
3
4
»
End
Page 3 of 4
Results 151 - 225 of 237
15
30
60
75
150
PAH: Risk Reduction Strategies Using Single and Combination Therapies
Ensuring Effective Care Transitions in Beta Thalassemia
Improved Patient Outcomes in PAH
IPF Management and Antifibrotic Therapy
A Collaborative Approach to IPF Management
Practical Solutions to SSc-ILD Treatment
Post COVID-19 and Patients With and Without Pre-existing ILD
Reversing DOACS: Providing Answers to What, Where and How
Reversing DOACS: Recording from Live Session held on July 18, 2021
Conquer the Clot: Addressing VTE in Your Patients with Cancer
Healthcare Disparities in African Americans With Myeloma
Perioperative Nutrition and Wound Healing
Special Considerations for Nutrition for the Elderly
Diabetes & Nutrition
Itching for Relief: Atopic Dermatitis Management Considerations for PAs and NPs
Exploring the Evidence, the Reality, and the Potential of CGM
COVID-19 Acute and Long-term Lung Injury
COVID-19 and ARDS: East Coast Experiences
Practical Questions in the Diagnosis and Management of Patients With MAC
COVID-19 and ARDS: West Coast Experiences
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
Advances in Multiple Sclerosis (AIMS) Primer: 3rd Edition
A Practical Guide to Rehabilitation in Multiple Sclerosis: 2nd Edition
Palliative Embolization
Vertebroplasty and Vertebral Augmentation for Spine Metastases or Pathologic Fractures
Effective Communication With Your Patient and Family
Palliative Ablations of Bone and Soft Tissue Tumors
Acute Exacerbations of IPF
Evaluation and Diagnosis of IPF
Initial Treatment Decisions of IPF
What if President Calvin Coolidge Was Your Asthma Patient?
Optimizing Management of IPF
How Would You Manage President Theodore Roosevelt’s Asthma Today?
Updates in Atopic Dermatitis: The Allergist’s Guide to Optimizing Care - Child
2019 Summer Pulmonary Updates: The Experts Weigh In
A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
How Pulmonary Arterial Hypertension Has Changed Iain’s Life
Biosimilars: Applying the Science to Hematology/Oncology Practice
Atopic Dermatitis: Recent and Emerging Therapies
An Introduction to Atopic Dermatitis
PAH Today: Mastering Current, Tailored Treatment
Achieving Better Control of Severe Asthma
A Personalized Approach to Managing Uncontrolled Asthma
Top Questions about Biosimilars in Dermatology
Top Questions about Biosimilars in Gastroenterology
Top Questions about Biosimilars in Rheumatology
Top Questions about Biosimilars in Hematology/Oncology
Biosimilars and Patients with Inflammatory Bowel Disease
Biosimilars: The New Era of Gastroenterology Management Considerations
Psoriasis Management Considerations: What Would You Do?
Jamie Develops Complications with Her Psoriasis
Psoriasis: Three Case Studies in the Primary Care Setting
Cindy Has a Complex Case of Psoriasis
Famous People with Diabetes: Ella Fitzgerald
Famous People with Diabetes: Jerry Garcia
Targeting B-cells in Primary Progressive MS (PPMS)
Comorbidities and Selection of DMTs
The Gut Microbiota in MS
Early MS: Induction Therapy and Escalation Strategies
Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS
Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options
Download Slides: Advancing T2DM Therapy with Confidence
Getting to Goal Can Be Difficult: Louise
Getting to Goal Can Be Difficult: Brian
Considering Biosimilars in Patients Failing their Initial Biologic
When to Switch? Biologically Experienced Patients with Spondyloarthritis
Innovator or Biosimilar for a Patient with Rheumatoid Arthritis
Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?
Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic
Innovator or Biosimilar for a Patient with Ulcerative Colitis?
Switching Between Biologics: Is a Biosimilar an Option?
When to Switch? Biologically Experienced Psoriasis Patients
Innovator or Biosimilar for a Patient with Psoriasis
Interchangeability and Pharmacy-Level Substitution
FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
Start
«
1
2
3
4
»
End
Page 3 of 4
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA
Search
Home
Education
Register
Contact Us
Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our
Privacy Policy
.
I accept